CNPY1

Across TCGA pan-cancer cohorts, CNPY1 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated CNPY1 data layer compared with 19 for mass-spec protein.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher CNPY1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated CNPY1 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

STAD, UCEC, and COAD are the cancer types where CNPY1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Median	All	0.226	0.691	<.001	60	view →
UCEC	DFS	Median	II,III,IV	1.000	0.441	.026	20	view →
COAD	OS	Median	All	0.508	0.873	.006	12	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

CNPY1–STAD (OS)

Open the STAD breakdown →